Elizabeth Blair to Anticarcinogenic Agents
This is a "connection" page, showing publications Elizabeth Blair has written about Anticarcinogenic Agents.
Connection Strength
0.133
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.133
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.